Drug trial aims to tame silent hormone problem linked to heart and bone risks
NCT ID NCT07247058
Summary
This study is testing if a drug called Isturisa (osilodrostat) can help people with a condition where a small adrenal tumor causes mildly high cortisol levels long-term. Researchers want to see if taking the drug for two years improves related health issues like blood sugar, weight, cholesterol, bone strength, and quality of life. The goal is to find a medication option for people who cannot or do not want to have surgery to remove the tumor.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD AUTONOMOUS CORTISOL SECRETION (MACS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Johns Hopkins University School of Medicine
RECRUITINGBaltimore, Maryland, 21205, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.